120 related articles for article (PubMed ID: 11535933)
1. Analysis of the expression of estrogen and progesteron receptors, and of PCNA and Ki67 proliferation antigens, in uterine myomata cells in relation to the phase of the menstrual cycle.
Zasławski R; Surowiak P; Dziegiel P; Pretnik L; Zabel M
Med Sci Monit; 2001; 7(5):908-13. PubMed ID: 11535933
[TBL] [Abstract][Full Text] [Related]
2. [The analysis of estrogen and pregesterone receptors in leiomyomas cell in different phases of menstrual cycle].
Zasławski R; Surowiak P; Pratnik L; Dziegiel P; Zabel M
Ginekol Pol; 2000 Apr; 71(4):375-80. PubMed ID: 10860276
[TBL] [Abstract][Full Text] [Related]
3. Cyclic changes in the mammary gland of cynomolgus macaques.
Stute P; Wood CE; Kaplan JR; Cline JM
Fertil Steril; 2004 Oct; 82 Suppl 3():1160-70. PubMed ID: 15474090
[TBL] [Abstract][Full Text] [Related]
4. MIB-1 (Ki-67), estrogen receptor, progesterone receptor, and p53 expression in atypical cells in uterine symplastic leiomyomas.
Sun X; Mittal K
Int J Gynecol Pathol; 2010 Jan; 29(1):51-4. PubMed ID: 19952937
[TBL] [Abstract][Full Text] [Related]
5. [Research on the relationship between estrogen receptor, progesterone receptor, cell proliferation associated antigen in uterine leiomyoma and nuclear body density of myoma, serum reproductive hormone concentrations].
Wu J; Cheng Y
Zhonghua Fu Chan Ke Za Zhi; 1995 Oct; 30(10):603-7. PubMed ID: 8745507
[TBL] [Abstract][Full Text] [Related]
6. The differential expression of oestrogen receptors, progesterone receptors, Bcl-2 and Ki67 in endometrial polyps.
Taylor LJ; Jackson TL; Reid JG; Duffy SR
BJOG; 2003 Sep; 110(9):794-8. PubMed ID: 14511960
[TBL] [Abstract][Full Text] [Related]
7. Cyclical change of hMSH2 protein expression in normal endometrium during the menstrual cycle and its overexpression in endometrial hyperplasia and sporadic endometrial carcinoma.
Hamid AA; Mandai M; Konishi I; Nanbu K; Tsuruta Y; Kusakari T; Kariya M; Kita M; Fujii S
Cancer; 2002 Feb; 94(4):997-1005. PubMed ID: 11920468
[TBL] [Abstract][Full Text] [Related]
8. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma.
Leitao MM; Soslow RA; Nonaka D; Olshen AB; Aghajanian C; Sabbatini P; Dupont J; Hensley M; Sonoda Y; Barakat RR; Anderson S
Cancer; 2004 Sep; 101(6):1455-62. PubMed ID: 15316901
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of heparin-binding epidermal growth factor-like growth factor on the growth of cultured human uterine leiomyoma cells and myometrial cells.
Wang J; Ohara N; Takekida S; Xu Q; Maruo T
Hum Reprod; 2005 Jun; 20(6):1456-65. PubMed ID: 15760954
[TBL] [Abstract][Full Text] [Related]
10. Different expression of estrogen receptors alpha and beta in human myometrium and leiomyoma during the proliferative phase of the menstrual cycle and after GnRHa treatment.
Wang H; Wu X; Englund K; Masironi B; Eriksson H; Sahlin L
Gynecol Endocrinol; 2001 Dec; 15(6):443-52. PubMed ID: 11826769
[TBL] [Abstract][Full Text] [Related]
11. Progesterone down-regulates insulin-like growth factor-I expression in cultured human uterine leiomyoma cells.
Yamada T; Nakago S; Kurachi O; Wang J; Takekida S; Matsuo H; Maruo T
Hum Reprod; 2004 Apr; 19(4):815-21. PubMed ID: 15033949
[TBL] [Abstract][Full Text] [Related]
12. Are there any differences in the expression of hormonal receptors and proliferation markers between uterine and extrauterine leiomyomas?
Sen N; Demirkan NC; Colakoglu N; Duzcan SE
Int J Surg Pathol; 2008 Jan; 16(1):43-7. PubMed ID: 18203783
[TBL] [Abstract][Full Text] [Related]
13. Cellular proliferation, estrogen receptor, progesterone receptor, and bcl-2 expression in GnRH agonist-treated uterine leiomyomas.
Vu K; Greenspan DL; Wu TC; Zacur HA; Kurman RJ
Hum Pathol; 1998 Apr; 29(4):359-63. PubMed ID: 9563785
[TBL] [Abstract][Full Text] [Related]
14. Differences in oestrogen and progesterone receptors, HER-2, p53 expression and proliferation in ductal breast cancers in relation to histopathological grade.
Zasławski R; Surowiak P; Paluchowski P; Dziegiel P; Maciejczyk A; Pudełko M; Wojnar A; Zabel M
Folia Morphol (Warsz); 2005 Feb; 64(1):9-15. PubMed ID: 15832264
[TBL] [Abstract][Full Text] [Related]
15. Menstrual cycle and hormone receptor status in breast cancer patients.
Atalay C; Kanliöz M; Altinok M
Neoplasma; 2002; 49(4):278. PubMed ID: 12382029
[TBL] [Abstract][Full Text] [Related]
16. Proliferative activity and level of steroid hormone receptors in the myometrium and myoma nodes in different phases of menstrual cycle.
Pavlovich SV; Volkov NI; Burlev VA
Bull Exp Biol Med; 2003 Oct; 136(4):396-8. PubMed ID: 14714093
[TBL] [Abstract][Full Text] [Related]
17. Variations in steroid hormone receptor content throughout age and menopausal periods, and menstrual cycle in breast cancer patients.
Nikolić-Vukosavljević D; Vasiljević N; Branković-Magić M; Polić D
Neoplasma; 1996; 43(3):163-9. PubMed ID: 8841503
[TBL] [Abstract][Full Text] [Related]
18. Two types of nuclear oestradiol binding sites in human myometrium and leiomyoma during the menstrual cycle.
Környei J; Csermely T; Székely JA; Vértes M
Exp Clin Endocrinol; 1986 Aug; 87(3):256-64. PubMed ID: 3780865
[TBL] [Abstract][Full Text] [Related]
19. Steroid hormone receptor expression and proliferation in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Qiu C; Shan L; Yu M; Snyderwine EG
Carcinogenesis; 2005 Apr; 26(4):763-9. PubMed ID: 15637090
[TBL] [Abstract][Full Text] [Related]
20. Cell proliferation and apoptosis in human uterine leiomyomas and myometria.
Dixon D; Flake GP; Moore AB; He H; Haseman JK; Risinger JI; Lancaster JM; Berchuck A; Barrett JC; Robboy SJ
Virchows Arch; 2002 Jul; 441(1):53-62. PubMed ID: 12111201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
